Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
The gap is that pharmaceutical manufacturers are studying these drugs for many more indications, including cardiovascular disease, liver disease, kidney disease, and other conditions well beyond weight loss
S., Shankey, T
The J Physiol Sci
176 GLP-1RAs and diseases As a rising star in recent years, GLP-1RAs are not only effective in metabolic diseases but also play a role in non-metabolic disorders, affecting multiple systems including the musculoskeletal, nervous, cardiovascular, and digestive systems, and can even have implications in oncological diseases
US$ 24.07
US$ 26.91
US$ 20.14
US$ 29.70
US$ 24.64
US$ 20.39
US$ 28.39
US$ 25.10
US$ 24.89
US$ 23.92
